Rather than focusing on a single therapy category, Oxymed has combined eight therapy modes into one device, positioning the ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

The medical device supplier said that a threat actor accessed company systems through a social engineering attack.

TORONTO — Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.

Why does the gap between high-performance engineering and market affordability continue to widen in the respiratory care sector? Is it possible to secure a reliable, long-term supply of micro-blowers ...

A Spanish trial finds positional therapy improves positional sleep apnea, is better tolerated than CPAP, and maintains benefits in many patients after treatment ends.

The scaled-backed Alibaba settlement reflects a broader trend by the DOJ of pulling back on criminal enforcement of corporate ...

A retrospective analysis of 1,575 patients drawn from a national cardiometabolic registry found that treating obstructive ...

Roughly one billion people worldwide are estimated to live with obstructive sleep apnea, and a large share of them don't know it. For the ones who do get diagno ...

The company has since learned the cyberattack was caused by a third-party contractor’s user session within its cloud-based ...